Herbas VPB

Print
EN | LT
Supplementary protection
LT - Glikopeptido fosfonato dariniai
EN - GLYCOPEPTIDE PHOSPHONATE DERIVATIVES
SPC
(11) Number of the document C 1292612
(68) Number of the document 1292612
(21) Application number for Supplementary Protection Certificate PA 2012 002
(22) Date of filing the application 2012-02-07
(41) Date of publication of the application 2012-03-26
Date of publication of SPC 2013-06-25
(24) Date of coming into effect of SPC 2021-05-02
Applicant
(71) Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA 94080, US
Grantee
(73) Theravance Biopharma Antibiotics IP, LLC, 901 Gateway Boulevard, South San Francisco, CA 94080, US
Attorney or representative
(74) Liudmila GERASIMOVIČ, IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/11/705/001, 2011 09 02 EU/1/11/705/002, 2011-09-02
Calculated date of expiry of the SPC
(94) 2026-05-02
Name of the product protected by the basic patent
(95) Telavancinum
Legal status
SPC lapsed (non-payment of fees for the main patent)
Last update date 2021-11-18